Drug profile · INN
dalfopristin
SYNERCID
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dalfopristin (SYNERCID) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN dalfopristin
Brand SYNERCID
Route INTRAVENOUS
Formulation INJECTABLE
Frequently asked questions
What is dalfopristin?
dalfopristin (SYNERCID) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for dalfopristin?
SYNERCID is a marketed brand name for dalfopristin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dalfopristin?
dalfopristin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.